| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Meridian Bioscience Inc. (LSE: 0K0K)
0K0K Technical Analysis
5
| As on 26th Jan 2023 0K0K STOCK Price closed @ 33.97 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 25.39 & Strong Buy for SHORT-TERM with Stoploss of 23.75 we also expect STOCK to react on Following IMPORTANT LEVELS. |
0K0KSTOCK Price
| Open | 33.97 | Change | Price | % |
| High | 33.97 | 1 Day | 0.02 | 0.06 |
| Low | 33.97 | 1 Week | 0.88 | 2.66 |
| Close | 33.97 | 1 Month | 1.46 | 4.49 |
| Volume | 100 | 1 Year | 15.48 | 83.72 |
| 52 Week High 33.97 | 52 Week Low 17.28 | ||||
LSE UK Most Active Stocks
| KOD | 0.26 | -13.33% |
| TRP | 0.03 | 0.00% |
| UKOG | 0.01 | 0.00% |
| MSMN | 0.02 | 0.00% |
| DEMG | 0.02 | -50.00% |
| ALBA | 0.02 | 0.00% |
| SMDS | 582.50 | 0.00% |
| DKE | 0.15 | 0.00% |
| NNN | 0.09 | 50.00% |
| GST | 0.78 | 0.00% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
| 0K0K Daily Charts |
0K0K Intraday Charts |
Whats New @ Bazaartrend |
0K0K Free Analysis |
|
|
0K0K Important Levels Intraday
| RESISTANCE | 33.97 |
| RESISTANCE | 33.97 |
| RESISTANCE | 33.97 |
| RESISTANCE | 33.97 |
| RESISTANCE | 33.97 |
| RESISTANCE | 33.97 |
| RESISTANCE | 33.97 |
| RESISTANCE | 33.97 |
0K0K Forecast November 2025
| 4th UP Forecast | 56.42 |
| 3rd UP Forecast | 49.22 |
| 2nd UP Forecast | 44.77 |
| 1st UP Forecast | 40.32 |
| 1st DOWN Forecast | 27.62 |
| 2nd DOWN Forecast | 23.17 |
| 3rd DOWN Forecast | 18.72 |
| 4th DOWN Forecast | 11.52 |
0K0K Weekly Forecast
| 4th UP Forecast | 42.29 |
| 3rd UP Forecast | 39.62 |
| 2nd UP Forecast | 37.97 |
| 1st UP Forecast | 36.32 |
| 1st DOWN Forecast | 31.62 |
| 2nd DOWN Forecast | 29.97 |
| 3rd DOWN Forecast | 28.32 |
| 4th DOWN Forecast | 25.65 |
0K0K Forecast2025
| 4th UP Forecast | 66.54 |
| 3rd UP Forecast | 56.09 |
| 2nd UP Forecast | 49.64 |
| 1st UP Forecast | 43.18 |
| 1st DOWN Forecast | 24.76 |
| 2nd DOWN Forecast | 18.3 |
| 3rd DOWN Forecast | 11.85 |
| 4th DOWN Forecast | 1.4 |
Meridian Bioscience Inc. ( LSE UK Symbol : 0K0K )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
0K0K Business Profile
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare and PediaStat brands; and urea breath testing for H. pylori under the BreathID brand. This segment also offers gastrointestinal assays, including tests for C. difficile, H. pylori, and certain foodborne pathogens; respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry assays for testing elevated levels of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. The company has a strategic collaboration with DiaSorin Inc. to sell H. pylori tests. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio. Address: 3471 River Hills Drive, Cincinnati, OH, United States, 45244
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service